Keharusan Penggunaan Ganja Untuk Maslahah Perubatan Kesihatan: Satu Perbincangan Awal [The Necessity Of Using Cannabis For Medical Health Importance: A Preliminary Discussion]
DOI:
https://doi.org/10.37231/jimk.2023.24.1.771Keywords:
Cannabis, Hemp, Cultivation, Health, Kanabis, Hemp, Ganja, Penanaman, KesihatanAbstract
Artikel ini menganalisis hukum penanaman kanabis atau ganja yang kerap diperbincangkan sejak kebelakangan ini khususnya dari segi manfaat terhadap keperluan perubatan kesihatan. Antara spesis kanabis yang dipercayai mengandungi manfaat kesihatan ialah hemp (Cannabis Sativa L.). Hemp dipercayai mampu bertindak sebagai terapi bagi pesakit gangguan saraf, autisme, kemurungan, parkinson dan kanser. Namun menurut undang-undang Malaysia, kanabis disenaraikan dalam Akta Dadah Berbahaya 1952 yang mengharamkan penanaman, pengeluaran, pengedaran, import, eskport, pemilikan dan penyalahgunaannya. Artikel ini juga bertujuan untuk meneliti asas-asas keharusan penanaman pokok tersebut daripada sudut pertimbangan maslahah dan mafsadah dalam konteks penjagaan maqasid syariah yang lebih luas. Sebagai sebuah kajian kualitatif, metod analisis kandungan akan digunakan bagi memperoleh pandangan fuqaha Islam mengenai hukum penanaman hasyish (ganja), khasykhasy (popi), tabg (tembakau) dan dan fatwa-fatwa semasa yang berkaitan daripada pelbagai institusi hukum yang berautoriti. Bagi menentukan hukumnya pada masa kini, aspek maslahah dan mafsadah perlu dipertimbangkan dengan mengambilkira ketetapan undang-undang negara. Seterusnya, kajian ini telah mendapati bahawa spesis hemp adalah suci dan tidak dianggap najis namun keharusan penanamannya tertakluk kepada beberapa garis panduan bagi mengelak timbulnya kesan kemudaratan kepada masyarakat.
This article analyses the ruling regarding the cultivation of cannabis or ganja which has often been discussed in recent times, particularly in terms of its benefits for medical health needs. Hemp is one of the varieties of cannabis thought to have health advantages (Cannabis Sativa L.). Patients with cancer, Parkinson's disease, depression, anxiety disorders, and autism may benefit from using hemp as a therapy. However, as per the Dangerous Drugs Act 1952 in Malaysia, cannabis is prohibited from being cultivated, produced, distributed, imported, exported, possessed, or abused. This article also aims to examine the fundamentals of the necessity of planting cannabis from the point of view of maslahah and mafsadah in the context of taking care of the wider shariah maqasid. As a qualitative study, the content analysis method will be employed to obtain the views of Islamic jurists regarding the legality of cultivating hasyish (marijuana), khasykhasy (poppy), tabg (tobacco) as well as the pertinent current fatwas from multiple reputable legal institutions. Today, the maslahah and mafsadah aspects must be taken into consideration while determining the law, keeping in mind the provisions of national law. Next, this study has shown that although the hemp species is sacred and not regarded as impure, its cultivation needs to adhere to a number of rules in order to prevent negative effects on the community
References
Agrawal, A., P. A. Madden, K. K. Bucholz, A. C. Heath, and M. T. Lynskey (2014) Initial reactions to tobacco and cannabis smoking: A twin study. Addiction 109(4):663–671.
Aizpurua-Olaizola O, et al. Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. J. Nat. Prod. 2016; 79:324–31.
al-Asqalani, Ibn Hajar (t.t). Fath al-Bari Syarh Sahih al-Bukhari. Beirut: Dar al-Ma’rifah.
Baker, D., G. Pryce, G. Giovannoni, and A. J. Thompson. 2003. The therapeutic potential of cannabis. The Lancet Neurology 2:291–298.
Basit Aijaz (2021). From Canada to Uruguay, Here Are Some Of The Countries Where Marijuana Is Legal. Diakses dari https://www.indiatimes.com/trending/social-relevance/countries-where-marijuana-is-legal-551710.html pada 3 Jun 2022.
Bergamaschi, M. M., R. H. Queiroz, M. H. Chagas, D. C. de Oliveira, B. S. De Martinis, F. Kapczinski, J. Quevedo, R. Roesler, N. Schröder, A. E. Nardi, R. MartÃn-Santos, J. E. Hallak, A. W. Zuardi, and J. A. Crippa (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 36(6):1219–1226.
BH Online, 10 September 2021. UniMAP kaji tanaman 'hemp'. Diakses dari https://www.bharian.com.my/berita/pendidikan/2021/09/862187/unimap-kaji-tanaman-hemp pada 2 Mei 2022.
BH Online, 6 November 2019. Kerajaan dalam proses benar penanaman 'hemp' untuk tujuan penyelidikan. Diakses dari https://www.bharian.com.my/berita/nasional/2019/11/625523/kerajaan-dalam-proses-benar-penanaman-hemp-untuk-tujuan-penyelidikan pada 2 Mei 2022.
Busse, F., L. Omidi, K. Timper, A. Leichtle, M. Windgassen, E. Kluge, and M. Stumvoll. 2008. Lead poisoning due to adulterated marijuana. New England Journal of Medicine 358(15):1641–1642.
Dar al-Ifta’ al-Misriyyah (2020). Ma Hukm Zira'at al-Mawad al-Mukhaddarah wa al-Mal al-Natij'an al-Ittijar fiha? Dar al-Ifta' Tujib. Diakses dari https://www.vetogate.com/4240280 pada 2 Mei 2022.
de Lago, E. and J. Fernandez-Ruiz (2007). Cannabinoids and neuroprotection in motor-related disorders. CNS and Neurological Disorders in Drug Targets 6(6):377–387
al-Disuqi, Muhammad ibn Arafah (t.t) Hasyiah al-Disuqi ‘ala al-Syarh al-Kabir. T.tp: Dar al-Fikr.
al-Dustur, 3 Oktober 2018. Hukm Zira'at al-Mukhaddarat wa al-Ittijar biha. Diakses dari https://www.dostor.org/2345891 pada 3 Mei 2022.
Enik Isnaini (2017). Penggunaan Ganja Dalam Ilmu Pengobatan Menurut Undang-Undang Nomor 35 Tahun 2009 Tentang Narkotika. Jurnal Independent. Vol 5, No 2 ;46-54.
Grotenhermen, F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics 42(4):327–360.
Grotenhermen, F., & Müller-Vahl, K. (2012). The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches Arzteblatt International, 109(29–30), 495–501.
al-Hattab, Muhammad ibn Muhammad al-Rucyani (1995). Mawahib al-Jalil fi Syarh Mukhtasar Khalil. Zakariyya Umayrat (Tahqiq). Edisi ke 1. Beirut: Dar al-Fikr.
Hillig K. Genetic evidence for speciation in Cannabis (Cannabaceae). Genet. Resour. Crop Evol. 2005;52(2):161–80.
Hofmann, M. E., and C. J. Frazier (2013) Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention. Experimental Neurology 244:43–50.
Ibn Abidin, Muhammad Amin ibn Umar (2000). Hasyiyah Radd al-Muhtar cala al-Durr al-Mukhtar. Beirut: Dar al-Fikr.
Ibn Majah, Muhammad ibn Yazid al-Qazwayni. (2009). Sunan Ibn Majah. Syucayb al-Arna’ut et.al (tahqiq). T.tp: Dar al-Risalah al-cAlamiyyah.
Ibn Qayyim, Muhammad Ibn Abi Bakr (1994). Zad al-Ma’ad fi Hadyy Khayr al-Ibad. Edisi ke-27. Beirut: Mu’assasah al-Risalah.
Ibn Taymiyyah, Ahmad ibn Abd al-Halim (2004). Majmuc Fatawa. Al-Madinah al-Munawwarah: Mujammak al-Malik Fahd li Tibacah al-Musyaf al-Syarif.
al-Ifta’ al-Urduni, 2012. Hukm al-Islam fi al-Mukhaddarat. Diakses dari https://www.aliftaa.jo/Article.aspx?ArticleId=161#.Ymi67tpBw2w pada 2 Mei 2022.
Iuvone, T., G. Esposito, D. De Filippis, C. Scuderi, and L. Steardo. 2009. Cannabidiol: A promising drug for neurodegenerative disorders? CNS Neuroscience and Therapeutics 15(1):65–75.
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009). Nonpsychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences, 30(10), 515–527.
Jerome H. Cherney (2016), Industrial Hemp in North America: Production, Politics and Potential, Agronomy 2016, 6(4), 58; https://doi.org/10.3390/agronomy6040058).
Johnson, 2009, Defining Hemp: A Fact Sheet, dalam https://www.everycrsreport.com/files/20190322_R44742_1b0195c6aa7e2cad29256c85a8574347c1ee833d.pdf).
Jones, N. A., A. J. Hill, I. Smith, S. A. Bevan, C. M. Williams, B. J. Whalley, and G. J. Stephens. 2010. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. Journal of Pharmacology and Experimental Therapeutics 332(2):569–577.
Jugl S., Okpeku A., Costales B., Morris E.J., Alipour-Haris G., Hincapie-Castillo J.M., Stetten N.E., Sajdeya R., Keshwani S., Joseph V., Zhang Y., Shen Y., Adkins L, Winterstein A.G, Goodin A. 2021. A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Med Cannabis Cannabinoids 2021; 4:21–42
Leong Abdullah. M.F.I., Mohamad M.A, Lan, T.M., Saidin, N.A, Rahman N.N.A. Ketum Perubatan Moden dan Perubatan Islam, Universiti Sains Malaysia, 2021
Leweke, F. M., J. K. Mueller, B. Lange, and C. Rohleder. 2016. Therapeutic potential of cannabinoids in psychosis. Biological Psychiatry 79(7):604–612.
Li, R. F., G. T. Lu, L. Li, H. Z. Su, G. F. Feng, Y. Chen, Y. Q. He, B. L. Jiang, D. J. Tang, and J. L. Tang. 2014. Identification of a putative cognate sensor kinase for the two-component response regulator HrpG, a key regulator controlling the expression of the hrp genes in Xanthomonas campestris pv. campestris. Environmental Microbiology 16(7):2053–2071.
Malaysiakini, 30 September 2021. Ganja rawat tikus Alzheimer: Respon positif - penyelidik UPM. Diakses dari https://www.malaysiakini.com/news/593431 pada 2 Mei 2022
McLaren, J., W. Swift, P. Dillon, and S. Allsop. 2008. Cannabis potency and contamination: A review of the literature. Addiction 103(7):1100–1109.
McPartland, J. M., D. J. Blanchon, and R. E. Musty. 2008. Cannabimimetic effects modulated by cholinergic compounds. Addiction Biology 13(3–4):411–415.
Mikuriya T. H. (1969). Marijuana in medicine: past, present, and future. California medicine, 110(1), 34–40.).
Misty Pratt et.al (2019). Benefits and harms of medical cannabis: a scoping review of systematic reviews
Muslim, Abu al-Husayn (t.t), Sahih Muslim. Muhammad Fu’ad Abd al-Baqi (Tahqiq). Beirut: Dar Ihya al-Turath al-cArabi.
myMetro, 25 November 2021. Dah tiba masa 'halalkan' kanabis, ketum untuk perubatan: Pakar. Diakses dari https://www.hmetro.com.my/rencana/2021/11/781332/dah-tiba-masa-halalkan-kanabis-ketum-untuk-perubatan-pakar pada 2 Mei 2022.
al-Natur, Khalidah Rabhi & al-Qudhah, Muhammad Ahmad (2014). Jarimah al-Mutajarah bi al-Mukhaddarat min Suwar Jarimah al-Ifsad fi al-Ard. Dirasat, Ulum al-Syari’ah wa al-Qanun. Jil. 4, bil. 1:268-289.
al-Nawawi, Muhy al-Din Yahya ibn Syaraf. (t.t). Al-Majmu’ Sharh al-Muhazzab. Damsyik: Dar al Fikr.
Al-Nawawi, Muhy al-Din Yahya ibn Syaraf. (2000). Sahih Muslim bi Syarh al-Nawawi. Tahqiq oleh Khalil Ma’mun Syiha. Edisi ke 7. Beirut: Dar al-Ma’rifah.
Potter, D. J., Clark, P., & Brown, M. B. (2008). Potency of D9 –THC and Other Cannabinoidsin Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology.Journal of Forensic Science, 53(1), 1–5
al-Qaradawi, Yusuf (2020). Ma Hukm Zira'at al-Hasyisy wa al-Tabg. Diakses dari https://www.youtube.com/watch?v=pKG7YeyzJ5E pada 3 Mei 2022.
Raber, J. C., S. Elzinga, and C. Kaplan. 2015. Understanding dabs: Contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing. Journal of Toxicological Science 40(6):797–803.
al-Ramli, Syams al-Din Muhammad ibn Abi al-cAbbas (2003). Nihayat al-Muhtaj ilaSyarh al-Minhaj. Edisi ke 3. Beirut: Dar al-Kutub al-Ilmiyyah.
Rock, E. M., Goodwin, J. M., Limebeer, C. L., Breuer, A., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2011). Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Psychopharmacology, 215, 505–512.
al-San’ani, Muhammad ibn Isma’il. (t.t). Subul al-Salam Syarh Bulugh al-Maram. Kaherah: Dar al-Hadith.
Sawler J, Stout JM, Gardner KM, Hudson D, Vidmar J, Butler L, et al. (2015) The Genetic Structure of Marijuana and Hemp. PLoS ONE 10(8): e0133292. https://doi.org/10.1371/journal.pone.0133292).
Shannon L. Datwyler Ph.D., George D. Weiblen, 2006, Genetic Variation in Hemp and Marijuana (Cannabis sativa L.) According to Amplified Fragment Length Polymorphisms†. Journal of Forensic Sciences, Volume51, Issue2. March 2006, Pages 371-375
Shirah B, H, Ahmed M, M: The Use of Cannabis for Medical Purposes in the Arab World. Med Cannabis Cannabinoids 2021; 4:72-74. doi: 10.1159/000510824).
al-Syarbini, Syams al-Din Muhammad al-Khatib (1994). Mughni al-Muhtaj Ila Ma’crifat Macaniy Alfaz al-Minhaj. Ali Muhammad Mucawwad & al-Mawjud, Adil Ahmad (Tahqiq). Beirut: Dar al-Kutub al-cIlmiyyah.
al-Tabrani, Sulayman ibn Ahmad (1994). al-Mucjam al-Awsat. Tahqiq oleh Tariq ibn cIwad Allah dan Abd al-Muhsin ibn Ibrahim al-Husayni. Kaherah: Dar al-Haramayn.
Thomas, A., G. L. Baillie, A. M. Phillips, R. K. Razdan, R. A. Ross, and R. G. Pertwee. 2007. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. British Journal of Pharmacology 150(5):613–623.
Thomas, B. F., and G. T. Pollard. 2016. Preparation and distribution of cannabis and cannabis-derived dosage formulations for investigational and therapeutic use in the United States. Frontiers in Pharmacology 7:285.
al-Tirmidhi, Abu Isa Muhammad ibn cIsa (1996). Al-Jamic al-Kabir. Basysyar cAwwad Macruf (Tahqiq). Edisi ke 1. Beirut: Dar al-Gharb al-Arabi.
Underhill, A. P. (1997. Current issues in Chinese Neolithic archeology. Journal of World Prehistory, 11(2), 103–160, dalam Pisanti S, Bifulco M. Medical Cannabis: A plurimillennial history of an evergreen.JCellPhysiol.2019;234:8342–8351.https://doi.org/10.1002/jcp.27725PISANTIANDBIFULCO|8351).
Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: results of a nationwide survey. International Journal of Clinical Practice, 59(3), 291–295.
Wee, M., Hassan, A. ., & Abdullah, A. (2022). Legalization of Hemp and the Contribution to Japanese Economy. WILAYAH: The International Journal of East Asian Studies, 11(1), 69–82. Retrieved from http://jice.um.edu.my/index.php/IJEAS/article/view/34575
Zach Walsh, Robert Callaway, Lynne Belle-Isle, Rielle Capler, Robert Kay, Philippe Lucas, Susan Holtzman, Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use, International Journal of Drug Policy, Volume 24, Issue 6, 2013,Pages 511-516,)
Downloads
Published
Issue
Section
License
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication.
Copyrights for articles published in JIMK journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.
